G
Gary Spitzer
Researcher at Saint Louis University
Publications - 148
Citations - 5476
Gary Spitzer is an academic researcher from Saint Louis University. The author has contributed to research in topics: Bone marrow & Chemotherapy. The author has an hindex of 36, co-authored 148 publications receiving 5325 citations. Previous affiliations of Gary Spitzer include University of North Carolina at Chapel Hill & University of Texas MD Anderson Cancer Center.
Papers
More filters
Journal ArticleDOI
High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.
Philip T,James O. Armitage,Gary Spitzer,F. Chauvin,Sundar Jagannath,Jean-Yves Cahn,Philippe Colombat,Anthony H. Goldstone,N. C. Gorin,M. Flesh +9 more
TL;DR: Patients who had had a complete remission in response to initial chemotherapy had a higher disease-free survival rate than those who had not, and patients with sensitive relapse had aHigher disease- free survival rates than those with resistant relapse.
Journal ArticleDOI
Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression
Eric D. Jacobsen,Jeff P. Sharman,Yasuhiro Oki,Ranjana H. Advani,Jane N. Winter,Celeste M. Bello,Gary Spitzer,Maria Corinna Palanca-Wessels,Dana A. Kennedy,Pamela Levine,Jing Yang,Nancy L. Bartlett +11 more
TL;DR: Overall, significant activity with brentuximab vedotin was observed in relapsed/refractory DLBCL, and responses occurred across a range of CD30 expression.
Journal ArticleDOI
High-Dose Cyclophosphamide, Carmustine, and Etoposide and Autologous Bone Marrow Transplantation for Relapsed Hodgkin's Disease
Sundar Jagannath,Karel A. Dicke,James O. Armitage,Fernando Cabanillas,Leonard J. Horwitz,Lijda Vellekoop,Axel R. Zander,Gary Spitzer +7 more
TL;DR: High-dose CBV chemotherapy and autologous bone marrow rescue proved to be effective as salvage therapy for a select group of heavily pretreated patients with relapsed Hodgkin's disease.
Journal ArticleDOI
Recombinant Human Granulocyte Colony-Stimulating Factor Hastens Granulocyte Recovery After High-Dose Chemotherapy and Autologous Bone Marrow Transplantation in Hodgkin's Disease
Kerry Taylor,Sundar Jagannath,Gary Spitzer,J. A. Spinolo,Susan L. Tucker,Beverly Fogel,Fernando Cabanillas,Fredrick B. Hagemeister,Lawrence M. Souza +8 more
TL;DR: RhG-CSF hastens granulocyte recovery after high-dose chemotherapy with ABMT in patients with relapsed/refractory Hodgkin's disease without significant toxicity.
Journal ArticleDOI
Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support.
Frank Dunphy,Gary Spitzer,Aman U. Buzdar,Gabriel N. Hortobagyi,L. J. Horwitz,Jonathan C. Yau,J. A. Spinolo,Sundar Jagannath,Frankie A. Holmes,Ralph O. Wallerstein +9 more
TL;DR: Longer follow-up is still needed to truly evaluate the possibility of long-term disease-free survival, but further studies of this approach to high-dose intensification in poor prognostic groups of stage IV breast cancer appear warranted.